In general, BRCA-mutated cancers are characterized by genomic instability due to deficient DNA repair by homologous recombination, which promotes the generation of neoantigens, robust cGAS-STING signaling and increased number of tumor infiltrating lymphocytes, making it an attractive target for ICB [69, 70]. The gene discussed is STING1; the disease is cancer.